Ranbaxy Laboratories LtdRANBAXY:NSI

Add to portfolio
Set alert
Interactive chart
Historical prices
Data definitions
450.80
20.70 / 4.39%
901.30k
7.43%
1.23
Latest price in INRToday's changeShares traded1 year changeBeta
As of May 20 2013 08:31 BST.Data delayed by at least 15 minutes.

Interactive chart

Summary

As of last trade , Ranbaxy Laboratories Ltd (RANBAXY:NSI) traded at 450.80, 21.57% above the 52 week low of 370.80 set on Mar 01, 2013.

52-week range
Today
370.80
Mar 01 2013
578.40
Sep 04 2012
Open472.10
Day high473.20
Day low450.20
Bid450.80
Offer450.95
Previous close471.50
Average volume1.22m
Shares outstanding423.10m
Free float154.46m
P/E (TTM)21.68
Market cap199.49bn INR
EPS (TTM)21.75 INR

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Ranbaxy Laboratories Ltd+2.79%-1.22%-12.57%-7.43%-11.70%
CNX NIFTY IDX+3.74%+7.29%+11.31%+26.84%+21.54%
IN/HEALTH CARE+3.27%+7.18%+18.99%+27.49%--
IN/PHARMACEUTICALS+3.36%+7.27%+20.01%+28.40%--
As of May 20 2013 08:31 BST.Data delayed by at least 15 minutes.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.